Search Results 1471-1480 of 13320 for monoclonal antibody

  1. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

    Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients ... A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to ...

  2. Kay L. Medina, Ph.D. - Mayo Clinic Faculty Profiles

    Medina, Ph.D., studies B lymphocyte biology. B lymphocytes are a special category of white blood cells that produce antibodies to fight infection. Defects in B ...

  3. A Study To Evaluate Ipilimumab Administered Intra-lymphatically Using The Sofusa® DoseConnect™ DEVICE With IV-administered Nivolumab In Patients With Metastatic Melanoma - Mayo Clinic

    History of severe hypersensitivity reactions to other monoclonal antibodies or known hypersensitivity to the study intervention or its excipients, indocyanine ...

  4. Study Of Efficacy And Safety Of PDR001 In Patients With Advanced Or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors Of Pancreatic, Gastrointestinal (GI), Or Thoracic Origin Or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) - Mayo Clinic

    History of severe hypersensitivity reactions to other monoclonal antibodies which in the opinion of the investigator may pose an increased risk of a serious ...

  5. Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) - Mayo Clinic

    Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or not recovered from an adverse event caused by mAbs administered more than 4 ...

  6. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

    ... monoclonal antibodies. Has evidence of ongoing uncontrolled systemic bacterial, fungal, or viral infection. Note: Subjects with localized fungal infections ...

  7. A Study to Assess the Effectiveness, Safety and Tolerability of Lu AF82422 in Patients with Multiple System Atrophy - Mayo Clinic

    - The participant has been treated with an anti-?-synuclein monoclonal antibody, mesenchymal stem cells or an inhibitor of ?-synuclein aggregation within ...

  8. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

    Prior treatment with a monoclonal antibody within 4 weeks prior to ... Known or suspected hypersensitivity to monoclonal antibodies; Currently ...

  9. SC16LD6.5 in Recurrent Small Cell Lung Cancer - Mayo Clinic

    5 will be assessed by measuring the extent of tumor shrinkage. SC16LD6.5 is an antibody-drug conjugate (ADC). The antibody (SC16) targets a protein that appears ...

  10. Venetoclax-Dexamethasone In Relapsed And/or Refractory T(11;14) Amyloidosis - Mayo Clinic

    38 (CD 38) monoclonal antibody - Participants with a history of autologous hematopoietic cell transplantation must have recovered from any transplant ...